All In MedTech

FDA Clearance Tracker · P030017-S377

Precision Spinal Cord Stimulator (SCS) Systems

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Jan 21, 2026 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Jan 21, 2026

Approved

Time to decision

541 days

Received Jul 29, 2024. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track

Device class

Class III

The decision

FDA number
P030017-S377
Device name
Precision Spinal Cord Stimulator (SCS) Systems
Applicant location
Valencia, CA
Received
Jul 29, 2024
Decided
Jan 21, 2026
Decision
Approved
Supplement type
Normal 180 Day Track
Reason for supplement
Change Design/Components/Specifications/Material
Original approval
P030017

Device type

Device class
Class III

Every decision under product code LGW

FDA's approval statement

As written in FDA's record.

Approval for the following changes related to the OR cables and extensions: 1) an alternate manufacturing site (i.e., Jiangyin SINBON Electronics Co. Ltd., FDA Establishment Identifier – 3007616088), 2) dimensional changes, 3) change of material for two polyurethane components (i.e., strain relief and cable jacket) to a trademarked thermoplastic polyurethane (i.e., IROGRAN A75E 5040), and 4) removal of a duplicative cleaning step.

Source documents

Other decisions for Boston Scientific Corp

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

7 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.